These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12032352)

  • 1. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization.
    Bale TL; Giordano FJ; Hickey RP; Huang Y; Nath AK; Peterson KL; Vale WW; Lee KF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7734-9. PubMed ID: 12032352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new role for corticotropin-releasing factor receptor-2: suppression of vascularization.
    Bale TL; Giordano FJ; Vale WW
    Trends Cardiovasc Med; 2003 Feb; 13(2):68-71. PubMed ID: 12586442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
    Wang H; Keiser JA
    Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.
    Korff T; Kimmina S; Martiny-Baron G; Augustin HG
    FASEB J; 2001 Feb; 15(2):447-57. PubMed ID: 11156960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
    Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
    Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
    FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency.
    Takeshita S; Rossow ST; Kearney M; Zheng LP; Bauters C; Bunting S; Ferrara N; Symes JF; Isner JM
    Am J Pathol; 1995 Dec; 147(6):1649-60. PubMed ID: 7495290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of apoptosis during angiogenesis by survivin expression in endothelial cells.
    O'Connor DS; Schechner JS; Adida C; Mesri M; Rothermel AL; Li F; Nath AK; Pober JS; Altieri DC
    Am J Pathol; 2000 Feb; 156(2):393-8. PubMed ID: 10666367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF spatially directs angiogenesis during metanephric development in vitro.
    Tufró A
    Dev Biol; 2000 Nov; 227(2):558-66. PubMed ID: 11071774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
    Montesano R; Kumar S; Orci L; Pepper MS
    Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.